Abstract
In this issue of Blood , [Scarfo et al][1] describe a novel subset of anaplastic lymphoma kinase (ALK)-negative anaplastic large-cell lymphoma (ALCL) associated with aberrant expression of ERBB4 transcripts and potential clinical relevance.[1][2] ![Figure][3] Schematic representation of
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
